Loading company details...
Latest Form 4 (Nov 16, 2026): Michael J. Deppe (SVP, Corp. Controller & CAO): Exercise/Conversion of 6,261 shares, $599.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 16, 2026 | Michael J. Deppe, SVP, Corp. Controller & CAO | Exercise/Conversion | 6,261 | $599.8K |
| Nov 13, 2026 | Patrick Plewman, SVP for Diagnostic Services | Exercise/Conversion | 4,274 | $545.9K |
| Nov 6, 2026 | Subu Ramachandran, SVP, Regional Businesses | Grant/Award | 352 | n/a |
| Nov 6, 2026 | Catherine T. Doherty, Executive Vice President | Grant/Award | 4,827 | n/a |
| Nov 6, 2026 | Mark E. Delaney, SVP & Chief Commercial Officer | Grant/Award | 2,615 | n/a |
| Oct 28, 2026 | Gary M. Pfeiffer | Sale | 1,203 | $292.3K |
| Oct 23, 2026 | Robert B. Carter | Small Acquisition | 10 | $2.4K |
| Oct 23, 2026 | Sam Samad, Executive Vice President & CFO | Grant/Award | 90 | $21.2K |
| Oct 23, 2026 | Vicky B. Gregg | Grant/Award | 63 | $14.9K |
| Oct 23, 2026 | Karthik Kuppusamy, SVP, Clinical Solutions | Small Acquisition | 33 | $7.8K |